Basically, during the resurrection of an old, successful drug, preclinical research has been ongoing to answer questions historical technology at the time of creation couldn't. There are many questions to answer, though, some of the most interesting are those relating to very unusual clinical activity for Bisantrene in 60+ historical clinical trials.
The work in October will finally tell the world about what Bisantrene is. It is like finding the right pair of glasses so you can finally read the fine print. Any potential partner or investor has to view the historical research from the new perspective this work presents. It just so happens that this is also a world first, an enormous first in class market opportunity, and an area of significant unmet clinical need in all regions of the world.
RAC Price at posting:
$1.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)